Advertisement

Intraocular Lymphomas

  • Kaustubh Mulay
  • Santosh G. Honavar
  • Santosh U. Kafle
  • Sarah E. CouplandEmail author
Chapter

Abstract

Lymphoma is a malignant neoplasm derived from monoclonal proliferations of B- or T-lymphocytes and rarely, natural killer (NK) cells. Ophthalmic involvement is relatively rare and may involve the ocular adnexa, orbit or intraocular structures. The intraocular lymphomas represent about 0.01% of ophthalmic diseases [1, 2]. They may arise as primary tumours within the eye, either within the vitreoretinal or uveal tract, or occur as secondary manifestations of a systemic Non-Hodgkin lymphoma (NHL). Vitreoretinal lymphomas (VRL) often occur in association with central nervous system (CNS) disease and are aggressive tumours. In contrast, primary uveal lymphomas tend to be low-grade B-NHL, and have a good prognosis. Secondary lymphomas represent an intraocular manifestation of a systemic NHL, and commonly occur in the choroid. Given their rarity and ability to masquerade clinically as inflammatory processes, the clinical diagnosis of intraocular lymphoma (both VRL and uveal lymphoma) is generally challenging, and typically requires a vitrectomy/chorioretinal biopsy for histopathological confirmation. Treatment of VRL is controversial and varies between centres, particularly in the absence of a concurrent CNS disease [2]. Although the earlier recognition of VRL has improved in recent times, the prognosis remains poor. Here, we summarize the available literature on both VRL and uveal lymphomas.

Keywords

Vitreoretinal lymphoma Uveal lymphoma Primary intraocular lymphoma 

References

  1. 1.
    Mochizuki M, Singh AD. Epidemiology and clinical features of intraocular lymphoma. Ocul Immunol Inflamm. 2009;17:69–72.PubMedCrossRefPubMedCentralGoogle Scholar
  2. 2.
    Davis J. Intraocular lymphoma: a clinical perspective. Eye. 2013;27:153–62.PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    Triebenstein O. Ein Beitrag zur Frage der aleukämischen Augenveränderungen. Klin Monatsbl Augenheilkd. 1920;64:825–36.Google Scholar
  4. 4.
    Cooper EL, Riker JL. Malignant lymphoma of the uveal tract. Am J Ophthalmol. 1951;34:1153–8.PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Givner I. Malignant lymphoma with ocular involvement: a clinico-pathologic report. Am J Ophthalmol. 1955;39:29–32.PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Klingele TG, Hogan MJ. Ocular reticulum cell sarcoma. Am J Ophthalmol. 1975;79:39–47.CrossRefGoogle Scholar
  7. 7.
    Vogel MH, Font RL, Zimmerman LE, Levine RA. Reticulum cell sarcoma of the retina and uvea. Report of six cases and review of the literature. Am J Ophthalmol. 1968;66:205–15.PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    Chan CC, Sen HN. Current concepts in diagnosis and managing primary vitreoretinal (intraocular) lymphoma. Discov Med. 2013;15:93–100.PubMedPubMedCentralGoogle Scholar
  9. 9.
    Char DH, Ljung BM, Miller T, Phillips T. Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management. Ophthalmology. 1988;95:625–30.PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Char DH, Ljung BM, Deschenes J, Miller TR. Intraocular lymphoma: immunological and cytological analysis. Br J Ophthalmol. 1988;72:905–11.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Qualman SL, Mendelsohn G, Mann RB, Green WR. Intraocular lymphomas. Natural history based on a clinicopathologic study of eight cases and review of the literature. Cancer. 1983;52:878–86.PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Coupland SE, Damato B. Understanding intraocular lymphomas. Clin Exp Ophthalmol. 2008;36:564–78.PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Chan CC, Rubenstein JL, Coupland SE, et al. Primary vitreoretinal lymphoma: a report from an international primary central nervous system lymphoma collaborative group symposium. Oncologist. 2011;16:1589–99.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Mulay K, Narula R, Honavar SG. Primary vitreoretinal lymphoma. Indian J Ophthalmol. 2015;63:180–6.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Coupland SE, Chan CC, Smith J. Pathophysiology of retinal lymphoma. Ocul Immunol Inflamm. 2009;17:227–37.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Jaffe ES, Harris NL, Stein H, Vardman JS. Tumours of hematologic and lymphoid tissues 2007. In: World Health Organization. classification of tumours. pathology and genetics. 4th ed. Lyon: IARC Press; 2008.Google Scholar
  17. 17.
    Sagoo MS, Mehta H, Swampillai AJ, et al. Primary intraocular lymphoma. Surv Ophthalmol. 2014;59:503–16.PubMedCrossRefGoogle Scholar
  18. 18.
    Bardenstein DS. Intraocular lymphoma. Cancer Control. 1998;5:317–25.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Schabet M. Epidemiology of primary CNS lymphoma. J Neuro-Oncol. 1999;43:199–201.CrossRefGoogle Scholar
  20. 20.
    Chan CC. Molecular pathology of primary intraocular lymphoma. Trans Am Ophthalmol Soc. 2003;101:275–92.PubMedPubMedCentralGoogle Scholar
  21. 21.
    Chan SM, Hutnik CM, Heathcote JG, et al. Iris lymphoma in a pediatric cardiac transplant recipient: clinicopathologic findings. Ophthalmology. 2000;107:1979–82.CrossRefGoogle Scholar
  22. 22.
    Wender A, Adar A, Maor E, et al. Primary B-cell lymphoma of the eyes and brain in a 3-year-old boy. Arch Ophthalmol. 1994;112:450–1.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Sobrin L, Dubovy SR, Davis JL, et al. Isolated, bilateral intraocular lymphoma in a 15-year-old girl. Retina. 2005;25:370–3.PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Berenbom A, Davila RM, Lin HS, et al. Treatment outcomes for primary intraocular lymphoma: implications for external beam radiotherapy. Eye. 2007;21:1198–201.PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Buettner H, Bolling JP. Intravitreal large cell lymphoma. Mayo Clin Proc. 1993;68:1101–5.CrossRefGoogle Scholar
  26. 26.
    Peterson K, Gordon KB, Heinmann MH, et al. The clinical spectrum of ocular lymphoma. Cancer. 1993;72:843–9.PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Chan CC, Shen DF, Whitcup SM, et al. Detection of human herpesvirus-8 and Epstein-Barr virus DNA in primary intraocular lymphoma. Blood. 1999;93:2749–51.CrossRefGoogle Scholar
  28. 28.
    Sauer TC, Meyers SM, Shen D, Vegh S, Vygantas C, Chan CC. Primary intraocular (retinal) lymphoma following ocular toxoplasmosis. Retin Cases Brief Rep. 2010;4:160–3.PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Kaplan LD. Human herpesvirus-8: Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma. Hematology Am Soc Hematol Educ Program. 2013;2013:103–8.PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Chan CC, Shen D, Hackett JJ, Buggage RR, Tuaillon N. Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma. Ophthalmology. 2003;110:421–6.CrossRefGoogle Scholar
  31. 31.
    McCann KJ, Ashton-Key M, Smith K, Stevenson FK, Ottensmeier CH. Primary central nervous system lymphoma: tumor-related clones exist in the blood and bone marrow with evidence for separate development. Blood. 2009;113:4677–88.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Cassoux N, Merle-Beral H, Leblond V, et al. Ocular and central nervous system lymphoma: clinical features and diagnosis. Ocul Immunol Inflamm. 2000;8:243–50.PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Coupland SE, Heimann H, Bechrakis NE. Primary intraocular lymphoma: review of clinical, histopathological and molecular biological features. Graefes Arch Clin Exp Ophthalmol. 2004;242:901–13.PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Lobo A, Larkin G, Clark BJ, et al. Pseudo-hypopyon as the presenting feature in B-cell and T-cell intraocular lymphoma. Clin Exp Ophthalmol. 2003;31:155–8.PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Dean JM, Novak MA, Chan CC, et al. Tumor detachments of the retinal pigment epithelium in ocular/central nervous system lymphoma. Retina. 1996;16:47–56.CrossRefGoogle Scholar
  36. 36.
    Gill MK, Jampol LM. Variations in the presentation of primary intraocular lymphoma: case reports and a review. Surv Ophthalmol. 2001;45:463–71.PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Matzkin DC, Slamovits TL, Rosenbaum PS. Simultaneous intraocular and orbital non-Hodgkin lymphoma in the acquired immune deficiency syndrome. Ophthalmology. 1994;101:850–5.PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Hochberg FH, Miller DC. Primary central nervous system lymphoma. J Neurosurg. 1988;68:835–53.CrossRefGoogle Scholar
  39. 39.
    Jang HS, Sepah YJ, Sophie R, et al. Longitudinal spectral domain optical coherence tomography changes in eyes with intraocular lymphoma. J Ophthalmic Inflamm Infect. 2013;3:59.PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Egawa M, Mitamura Y, Hayashi Y, Naito T. Spectral-domain optical coherence tomographic and fundus autofluorescence findings in eyes with primary intraocular lymphoma. Clin Ophthalmol. 2014;8:335–41.PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Folgar FA, Chow JH, Farsiu S, et al. Spatial correlation between hyperpigmentary changes on color fundus photography and hyperreflective foci on SDOCT in intermediate AMD. Invest Ophthalmol Vis Sci. 2012;53:4626–33.CrossRefGoogle Scholar
  42. 42.
    Ota M, Nishijima K, Sakamoto A, et al. Optical coherence tomographic evaluation of foveal hard exudates in patients with diabetic maculopathy accompanying macular detachment. Ophthalmology. 2010;117:1996–2002.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Fardeau C, Lee CP, Merle-Beral H, et al. Retinal fluorescein, indocyanine green angiography, and optic coherence tomography in non-Hodgkin primary intraocular lymphoma. Am J Ophthalmol. 2009;147:886–94.PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Fardeau C, Lee CP, Merle-Beral H, et al. Retinal fluorescein, indocyanine green angiography, and optical coherence tomography in non-Hodgkin primary intraocular lymphoma. Am J Ophthalmol. 2009;147:886–94.PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Casady M, Faia L, Nazemzadeh M, Nussenblatt R, Chan CC, Sen HN. Fundus autofluorescence patterns in primary intraocular lymphoma. Retina. 2014;34:366–72.PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Mudhar HS, Sheard R. Diagnostic cellular yield is superior with full pars plana vitrectomy compared with core vitreous biopsy. Eye (Lond). 2013;27:50–5.CrossRefGoogle Scholar
  47. 47.
    Whitcup SM, Chan CC, Buggage RR, et al. Improving the diagnostic yield of vitrectomy for intraocular lymphoma. Arch Ophthalmol. 2000;118:446.PubMedPubMedCentralGoogle Scholar
  48. 48.
    Cursiefen C, Holbach LM, Lafaut B, et al. Oculocerebral non-Hodgkin’s lymphoma with uveal involvement: development of an epibulbar tumor after vitrectomy. Arch Ophthalmol. 2000;118:1437–40.PubMedCrossRefPubMedCentralGoogle Scholar
  49. 49.
    Jack CR Jr, O’Neil BP, Banks PM, et al. Central nervous system lymphoma: histologic types and CT appearance. Radiology. 1988;167:211–5.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    DeAngelis LM. Primary central nervous system lymphomas. Curr Treat Options in Oncol. 2001;2:309–18.CrossRefGoogle Scholar
  51. 51.
    Gonzales JA, Chan CC. Biopsy techniques and yields in diagnosing primary intraocular lymphoma. Int Ophthalmol. 2007;27:241–50.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Whitcup SM, de Smet MD, Rubin BI, et al. Intraocular lymphoma. Clinical and histopathologic diagnosis. Ophthalmology. 1993;100:1399–406.PubMedCrossRefPubMedCentralGoogle Scholar
  53. 53.
    Michels RG, Knox DL, Erozan YS, et al. Intraocular reticulum cell sarcoma. Diagnosis by pars plana vitrectomy. Arch Ophthalmol. 1975;93:1331–5.PubMedCrossRefPubMedCentralGoogle Scholar
  54. 54.
    Chan CC, Buggage RR, Nussenblatt RB. Intraocular lymphoma. Curr Opin Ophthalmol. 2002;13:411–8.PubMedCrossRefPubMedCentralGoogle Scholar
  55. 55.
    Chan CC, Wallace DJ. Intraocular lymphoma: update on diagnosis and management. Cancer Control. 2004;11:285–95.PubMedPubMedCentralCrossRefGoogle Scholar
  56. 56.
    Chan CC, Gonzalez JA. Primary intraocular lymphoma. Hackensack, NJ: World Scientific; 2007.CrossRefGoogle Scholar
  57. 57.
    Mihaljević B, Sretenović A, Jaković L, et al. A case of primary peripheral T-cell type non-Hodgkin lymphoma originating in the iris—clinicopathological findings. Vojnosanit Pregl. 2010;67:1025–8.PubMedCrossRefPubMedCentralGoogle Scholar
  58. 58.
    Park CY, Hwang SW, Kim do Y, Huh HJ, Oh JH. Anaplastic large cell lymphoma involving anterior segment of the eye. Korean J Ophthalmol. 2014;28:108–12.PubMedPubMedCentralCrossRefGoogle Scholar
  59. 59.
    Blay JY, Favrot M, Rossi JF, Wijdenes J. Role of interleukin-6 in paraneoplastic thrombocytosis. Blood. 1993;82:2261–2.PubMedCrossRefPubMedCentralGoogle Scholar
  60. 60.
    Chan CC, Whitcup SM, Solomon D, Nussenblatt RB. Interleukin-10 in the vitreous of patients with primary intraocular lymphoma. Am J Ophthalmol. 1995;120:671–3.PubMedCrossRefPubMedCentralGoogle Scholar
  61. 61.
    Cassoux N, Merle-Beral H, Lehoang P, et al. Interleukin-10 and intraocular-central nervous system lymphoma. Ophthalmology. 2001;108:426–7.PubMedCrossRefPubMedCentralGoogle Scholar
  62. 62.
    Coupland SE, Bechrakis NE, Anastassiou G, et al. Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with Masquerade syndrome. Graefes Arch Clin Exp Ophthalmol. 2003;241(10):860–70.PubMedCrossRefPubMedCentralGoogle Scholar
  63. 63.
    Coupland SE, Hummel M, Müller HH, et al. Molecular analysis of immunoglobulin genes in primary intraocular lymphoma. Invest Ophthalmol Vis Sci. 2005;46(10):3507–14.PubMedCrossRefPubMedCentralGoogle Scholar
  64. 64.
    Bonzheim I, Giese S, Deuter C, et al. High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma: a valuable tool to improve diagnostic yield of vitreous aspirates. Blood. 2015;126(1):76–9.  https://doi.org/10.1182/blood-2015-01-620518.CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Wallace DJ, Shen D, Reed GF, et al. Detection of the bcl-2 t(14;18) translocation and proto-oncogene expression in primary intraocular lymphoma. Invest Ophthalmol Vis Sci. 2006;47:2750–6.PubMedPubMedCentralCrossRefGoogle Scholar
  66. 66.
    Jaehne D, Coupland SE. Primary vitreoretinal lymphoma. Ophthalmologe. 2018;115:343–56.  https://doi.org/10.1007/s00347-018-0681-5.CrossRefGoogle Scholar
  67. 67.
    Hoang-Xuan K, Bessell E, Bromberg J, et al. Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology. Lancet Oncol. 2015;16(7):e322–32.  https://doi.org/10.1016/S1470-2045(15)00076-5.CrossRefPubMedPubMedCentralGoogle Scholar
  68. 68.
    Nguyen DT, Houillier C, Choquet S, et al. Primary oculocerebral lymphoma: MTX polychemotherapy alone on intraocular disease control. Ophthalmology. 2016;123(9):2047–50.  https://doi.org/10.1016/j.ophtha.2016.03.043.CrossRefPubMedPubMedCentralGoogle Scholar
  69. 69.
    Soussain C, Suzan F, Hoang-Xuan K, et al. Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma. J Clin Oncol. 2001;19(3):742–9.CrossRefGoogle Scholar
  70. 70.
    Fend F, Ferreri AJ, Coupland SE. How we diagnose and treat vitreoretinal lymphoma. Br J Haematol. 2016;173(5):680–92.CrossRefGoogle Scholar
  71. 71.
    Deckert M, Engert A, Brück W, et al. Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma. Leukemia. 2011;25(12):1797–807.PubMedCrossRefPubMedCentralGoogle Scholar
  72. 72.
    Ferreri AJ, Zucca E, Armitage J, et al. Ten years of international primary CNS lymphoma collaborative group studies. J Clin Oncol. 2013;31(27):3444–5.PubMedCrossRefPubMedCentralGoogle Scholar
  73. 73.
    Itty S, Olson JH, O’Connell DJ, et al. Treatment of primary intraocular lymphoma (PIOL) has involved systemic, intravitreal or intrathecal chemotherapy and/or radiotherapy. Retina. 2009;29(3):415–6.PubMedCrossRefPubMedCentralGoogle Scholar
  74. 74.
    Grimm SA, McCannel CA, Omuro AM, et al. Primary CNS lymphoma with intraocular involvement: international PCNSL Collaborative Group Report. Neurology. 2008;71(17):1355–60.PubMedPubMedCentralCrossRefGoogle Scholar
  75. 75.
    Marshall MJE, Stopforth RJ, Cragg MS. Therapeutic antibodies: what have we learnt from targeting CD20 and where are we going? Front Immunol. 2017;8:1245.PubMedPubMedCentralCrossRefGoogle Scholar
  76. 76.
    Lionakis MS, Dunleavy K, Roschewski M, et al. Inhibition of B cell receptor signaling by ibrutinib in primary CNS lymphoma. Cancer Cell. 2017;31(6):833–43.PubMedPubMedCentralCrossRefGoogle Scholar
  77. 77.
    Onea AS, Jazirehi AR. CD19 chimeric antigen receptor (CD19 CAR)-redirected adoptive T-cell immunotherapy for the treatment of relapsed or refractory B-cell non-Hodgkin’s lymphomas. Am J Cancer Res. 2016;6(2):403–24.PubMedPubMedCentralGoogle Scholar
  78. 78.
    Shiratori E, Itoh M, Tohda S. MYD88 inhibitor ST2825 suppresses the growth of lymphoma and Leukaemia cells. Anticancer Res. 2017;37(11):6203–9.PubMedPubMedCentralGoogle Scholar
  79. 79.
    Coupland SE, Foss HD, Hidayat AA. Extranodal marginal zone B cell lymphomas of the uvea: an analysis of 13 cases. J Pathol. 2002;197(3):333–40.PubMedCrossRefPubMedCentralGoogle Scholar
  80. 80.
    Neudorfer M, Kessler A, Anteby I, et al. Co-existence of intraocular and orbital lymphoma. Acta Ophthalmol Scand. 2004;108:426–7.Google Scholar
  81. 81.
    Karakawa A, Taoka K, Kaburaki T, et al. Clinical features and outcomes of secondary intraocular lymphoma. Br J Haematol. 2017;183:668–71.  https://doi.org/10.1111/bjh.15005. CrossRefGoogle Scholar
  82. 82.
    Kim JL, Mendoza P, Rashid A, Hayek B, Grossniklaus HE. Optic nerve lymphoma. Report of two cases and review of the literature. Surv Ophthalmol. 2015;60:153–65.PubMedCrossRefPubMedCentralGoogle Scholar
  83. 83.
    Savino G, Petroni S, Balia L, et al. Secondary orbital and intraocular lymphoma treated with immunochemotherapy. Retin Cases Brief Rep. 2013;7:267–70.PubMedCrossRefPubMedCentralGoogle Scholar
  84. 84.
    Park CY, Hwang SW, Kim DY, Huh HJ, Oh JH. Anaplastic large cell lymphoma involving anterior segment of the eye. Korean J Ophthalmol. 2014;28:108–12.PubMedCentralCrossRefPubMedGoogle Scholar
  85. 85.
    Say EA, Knupp CL, Gertsch KR, Chavala SH. Metastatic B-cell lymphoma masquerading as infectious retinitis and vasculitis. Oncol Lett. 2012;3:1245–8.PubMedPubMedCentralCrossRefGoogle Scholar
  86. 86.
    Chi M, Bucher N, Gabrielian A, MacCumber MW, Zdunek T. Subcutaneous diffuse large B-cell lymphoma with intraocular involvement. Future Oncol. 2012;8:757–60.PubMedCrossRefPubMedCentralGoogle Scholar
  87. 87.
    Corrêa ZM, Augsburger JJ, Dalal MD, Spaulding A. Secondary intraocular uveal involvement by primary paranasal sinus lymphoma. Int Ophthalmol. 2012;32:397–400.PubMedCrossRefPubMedCentralGoogle Scholar
  88. 88.
    Cao X, Shen D, Callanan DG, Mochizuki M, Chan C-C. Diagnosis of systemic metastatic retinal lymphoma. Acta Ophthalmol. 2011;89:149–54.CrossRefGoogle Scholar
  89. 89.
    Salomão DR, Pulido JS, Johnston PB, et al. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma. JAMA Ophthalmol. 2013;131(9):1151–8.PubMedCrossRefPubMedCentralGoogle Scholar
  90. 90.
    Iwase T, Sugiyama K, Takahira M, Uchiyama A. Intraocular lymphoma metastasis from larynx. Eur J Ophthalmol. 2007;17:133–5.PubMedCrossRefPubMedCentralGoogle Scholar
  91. 91.
    Wallace DJ, Altemare CR, Shen DF, et al. Primary testicular and intraocular lymphomas: two case reports and a review of the literature. Surv Ophthalmol. 2006;51:41–50.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  • Kaustubh Mulay
    • 1
  • Santosh G. Honavar
    • 2
  • Santosh U. Kafle
    • 3
    • 4
  • Sarah E. Coupland
    • 4
    Email author
  1. 1.National Reporting Centre for Ophthalmic Pathology (NRCOP), Centre For SightHyderabadIndia
  2. 2.Department of Ophthalmic and Facial Plastic Surgery and Ocular Oncology, Centre For SightHyderabadIndia
  3. 3.Department of Ophthalmic Pathology and Laboratory MedicineEastern Regional Eye Care Program, Biratnagar Eye HospitalBiratnagarNepal
  4. 4.Department of Molecular and Clinical Cancer MedicineInstitute of Translational Medicine, University of LiverpoolLiverpoolUK

Personalised recommendations